New Law Creates Stricter Safety Standards for Drug Compounding Facilities

by

Michael D. Ponce

Last Updated November 22, 2013 In Drug Injury

November 22, 2013

Last year, 153 Tennesseans were sickened by contaminated steroid injections manufactured by a compounding pharmacy. Investigators later determined that a gap between state and federal law had allowed the defective medications to make their way onto the market.

The Nashville Meningitis Outbreak Lawyers with Ponce Law state that legislators addressed the issue recently by passing a bill that creates more stringent regulation of the drug compounding industry. Officials hope the move will improve the safety of compounded medications and to prevent similar situations from occurring.

An article published by The Tennessean explains the bill would allow “large-scale” compounding facilities to register with the U.S. Food and Drug Administration as an outsourcing provider. The title would create a sense of accreditation through a series of regular inspections considered more rigid than other testing and examination of practices.

While some fully support the changes to regulations, others say the reform will still hold compounding facilities to the same standards of operation that are upheld at traditional drug manufacturing facilities.

Michael D. Ponce & Associates has a team of Nashville Personal Injury Lawyers that recognizes the dangers contaminated drugs pose to the public and are hopeful the new regulations are effective in preventing future drug injuries.